Aqueous Suppressant Therapy Simon Law Md
Ppt Approach To The Patient With Cough Powerpoint Presentation Free Aqueous suppressant therapy on hypertensive phase after ahmed glaucoma valvesimon k. law, mducla stein eye institute. The purposes of this study were: (1) to prospectively evaluate hp characteristics in eyes receiving early aqueous suppressant therapy after implantation of the flexible sili cone agv (model fp 7); and (2) to analyze the effect of aqueous suppressant therapy initiation at 2 different levels of iop (>10 vs. >17 mm hg).
Pdf The Effect Of Early Versus Delayed Postoperative Aqueous Dr. simon k. law is a ophthalmologist in los angeles, ca. sherwin isenberg md (3 5) los angeles, ca. reginald ariyasu md early aqueous suppressant therapy on hypertensive phase following. Reprints: simon k. law, md, pharmd, glaucoma division, jules stein eye institute, david geffen school of medicine, university of california los angeles, 100 stein plaza #2 235, los angeles, ca 90095 (e mail: [email protected]). received december 12, 2013. accepted august 21, 2014. Law et al. evaluated 52 eyes undergoing agv implantation that were randomized to initiate aqueous suppressant therapy when postoperative iop was higher than 10 mmhg in one group or higher than 17. By attenuating the inflammatory processes underlying the hp, early aqueous suppression therapy may improve surgical outcomes and reduce the risk of surgical failure at month 12. ophthalmologists may use these findings to consider early initiation of aqueous suppressants following agv surgery to optimize patient outcomes.
Effects Of Aqueous Suppressants And Prostaglandin Analogues On Early Law et al. evaluated 52 eyes undergoing agv implantation that were randomized to initiate aqueous suppressant therapy when postoperative iop was higher than 10 mmhg in one group or higher than 17. By attenuating the inflammatory processes underlying the hp, early aqueous suppression therapy may improve surgical outcomes and reduce the risk of surgical failure at month 12. ophthalmologists may use these findings to consider early initiation of aqueous suppressants following agv surgery to optimize patient outcomes. Early aqueous suppressant therapy on hypertensive phase following glaucoma drainage device procedure: a randomized prospective trial. j glaucoma. 2016 mar; 25(3):248 57. law sk , kornmann hl, giaconi ja , kwong a, tran e, caprioli j. pmid: 25265004. Therapy initiated before the development of hp was not associated with a higher complication rate. conclusions: aqueous suppression initiated in the early postoperative period while iops were still in the low teens and was able to reduce the incidence of iop spike associated with the hp without an increased complication rate.
Comments are closed.